Dopamine Agents (administration & dosage) < Dopamine Agents (adverse effects) < Dopamine Agents (blood)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 50.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000217 (2000)	C W Olanow [États-Unis] ; A H Schapira ; T. Roth	Waking up to sleep episodes in Parkinson's disease.
000235 (2000)	V G Evidente [États-Unis] ; C H Adler ; J N Caviness ; J G Hentz ; K. Gwinn-Hardy	Amantadine is beneficial in restless legs syndrome.
000297 (2000)	J. Kulisevsky [Espagne] ; C. García-Sánchez ; M L Berthier ; M. Barbanoj ; B. Pascual-Sedano ; A. Gironell ; A. Estévez-González	Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients.
000314 (2000)	E. Růzicka [République tchèque] ; J. Roth ; R. Jech ; P. Busek	Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease.
000329 (2000)	S A Treseder [Royaume-Uni] ; L A Smith ; P. Jenner	Endogenous dopaminergic tone and dopamine agonist action.
000390 (2000)	K J Black [États-Unis] ; J W Mink	Response to levodopa challenge in Tourette syndrome.
000458 (2001)	H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C Hirsch	Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000461 (2001)	G M Petzinger [États-Unis] ; M. Quik ; E. Ivashina ; M W Jakowec ; M. Jakubiak ; D. Di Monte ; J W Langston	Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate.
000634 (2001)	B. Högl ; K. Seppi ; E. Brandauer ; G. Wenning ; Werner Poewe [Autriche]	Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): placebo-controlled, polysomnographic case report.
000647 (2002)	Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta Imperato	Neuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000991 (2003)	Peter Teismann [États-Unis] ; Kim Tieu ; Oren Cohen ; Dong-Kug Choi ; Du Chu Wu ; Daniel Marks ; Miquel Vila ; Vernice Jackson-Lewis ; Serge Przedborski	Pathogenic role of glial cells in Parkinson's disease.
000B37 (1992)	M R Luquin ; O. Scipioni ; J. Vaamonde ; O. Gershanik ; J A Obeso	Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
000B38 (1992)	S A Factor [États-Unis] ; D. Brown	Clozapine prevents recurrence of psychosis in Parkinson's disease.
000C26 (2003)	Michael P. Hill [Royaume-Uni] ; Erwan Bezard ; Steven G. Mcguire ; Alan R. Crossman ; Jonathan M. Brotchie ; Ann Michel ; Renee Grimée ; Henrik Klitgaard	Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset.
000D51 (2004)	Nicola Pavese [Royaume-Uni] ; Ornella Rimoldi ; Alexander Gerhard ; David J. Brooks ; Paola Piccini	Cardiovascular effects of methamphetamine in Parkinson's disease patients.
000E63 (2004)	Gurutz Linazasoro [Espagne]	Recent failures of new potential symptomatic treatments for Parkinson's disease: causes and solutions.
001025 (2004)	Arthur S. Walters [États-Unis] ; William G. Ondo ; Tilman Dreykluft ; Ron Grunstein ; Daniel Lee ; Kapil Sethi	Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
001074 (2005)	Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Ghassan Al-Barghouthy ; Sarah Rose ; Mikko Kuoppamaki ; Warren Olanow ; Peter Jenner	Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.
001633 (2006)	Juan Carlos G Mez-Esteban [Espagne] ; Juan Jose Zarranz ; Elena Lezcano ; Fernando Velasco ; Roberto Ciordia ; Idoia Rouco ; Jose Losada ; Iker Bilbao	Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.
001657 (2006)	Klaus Seppi [Autriche] ; Birgit Högl ; Anja Diem ; Cecilia Peralta ; Gregor K. Wenning ; Werner Poewe [Autriche]	Levodopa-induced sleepiness in the Parkinson variant of multiple system atrophy.
001821 (2007)	John G. Nutt [États-Unis]	Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dopamine Agents (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Dopamine Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Agents (adverse effects)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024